MAPT and supranuclear palsy, progressive, 1: The most important finding was that there are increased levels of both total and 4R tau mRNA in the brain tissue of patients with autopsy-confirmed PSP in the cerebellum but not the temporal cortex, indicating MAPT-specific expression changes in a brain region more vulnerable to degeneration in this disease.